Shares of Ascendis Pharma (ASND) are down $5.82, or 4%, to $155.33 in morning trading in New York. The move lower began near the open and may be related to the start of today’s Committee for ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

Allecra – which licenses enmetazobactam from Indian drugmaker Orchid Pharma – said the approval has unlocked a five-year marketing exclusivity extension from the FDA as part of the GAIN Act ...

Bonus Sep 15, 2005 Sep 17, 2005 Jul 18, 2005 Bonus Ratio: 1 share(s) for every 2 shares held Rights Jan 09, 1995 Feb 01, 1995 Mar 15, 1995 Rights ratio: 1 share for every 1 held at a price of Rs 40.0 ...

Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is ...

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.